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Medical applications of the superantioxidant ceria nanoparticles (CeNP) are limited by their 
high toxicity and low stability. CeNP toxicity is related to its aggregation in solution, and the 
possible generation of reactive oxidative species (ROS) by a Fenton-like reaction. For efficient 
medical applications it is necessary to find new solutions, which simultaneously reduce CeNP 
inherent toxicity while preserving their unique catalytic regenerative qualities. Here we 
introduce a straightforward strategy based on CeNP encapsulation in polymer vesicles which 
reduces their toxicity, but preserves their superantioxidant character. We have engineered 
antioxidant nanoreactors, which serve the dual role of: (i) separation of CeNP particles, which 
inhibits aggregate formation, and (ii) protection of CeNP from hydrogen peroxide, thus 
eliminating the Fenton-like reaction which induces cytotoxicity. Nanoreactors containing 
CeNP possess a higher scavenging activity than free CeNP for both hydroxyl and superoxide 
radicals, as indicated by spin trapping EPR. Due to the regenerative redox chemistry of ceria, 
the nanoreactors are active for long periods of time, without requiring additional reducing 
agents. Upon uptake by cells, the nanoreactors show almost no toxicity compared with free 
CeNP after long term exposure, thus proving their high efficacy as ROS scavengers. Our 
strategy of engineering CeNP-containing nanoreactors represents a versatile, simple and 
economical solution to reduce CeNP toxicity, while preserving their functionality; thus 
nanoreactors are ideal candidates for fighting oxidative stress in a large variety of medical 
situations. 
 
 
 
 
 
 
 
 
Introduction 
Oxidative stress induces an imbalance of reactive oxygen 
species (ROS), which may overwhelm cellular defences that are 
regulated by a plethora of molecules with antioxidant activity 
(glutathione, ascorbate, glutathione peroxidase, glutathione 
transferase, superoxide dismustase or catalase), 1 and thus cause 
toxicity effects. Due to the impact of oxidative stress in a 
variety of pathologic conditions, there are now significant 
efforts to identify efficient solutions to fight against diseases 
such as cancer, atherosclerosis, Parkinson’s disease, 
Alzheimer’s disease, diabetes, inflammation, or 
neurodegeneration 2,3. One of the most efficient strategies based 
on nanoscience concepts has proved to be the design of 
nanoreactors by  encapsulation in polymer vesicles of 
antioxidant enzymes, such as superoxide dismutase, 4,5 
hemoglobin, 6 superoxide dismutase and lactoperoxidase, 7,8 or 
superoxide dismutase mimics 9. Nanoreactors represent 
compartments with nanometer sizes in which defined chemical 
reactions take place 10,11,12,13. They are designed to contain 
within their architecture the desired catalysts (enzymes, 
proteins, mimics or combinations of thereof), which are 
shielded from environmental degradation, while acting in situ 
14,6,15. Compared to conventional drug delivery systems in 
which the antioxidant compounds are active upon release 16, the 
use of nanoreactors has the advantage of maintaining in situ 
antioxidant activity for long periods of time, because of the 
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shielding effect of polymer vesicles. However, a reduced 
encapsulation efficiency of enzymes due either to inherent low 
solubility or to the statistical co-encapsulation process 
represents a limiting factor that is still to be addressed. While 
improved encapsulation efficiency is obtained by encapsulation 
in nanoreactors of small molecular mass mimics, 6 the intrinsic 
activity of mimics is lower than the corresponding enzymes. To 
the best of our knowledge, the combined effect of high 
encapsulation efficiency and highly active compounds has not 
been yet solved. 
Ceria nanoparticles (CeNP) have been used as superantioxidant 
systems in various domains, ranging from material engineering 
and the car industry to electrolytic material for solid oxide fuel 
cells 17,18,19. CeNP are based on ceria (CeO2), a cubic fluorite 
type oxide whose catalytic activity is due to repetitive cycling 
between the Ce4+ and Ce3+ oxidation states. Oxygenation-
deoxygenation cycles without disruption of the fluorite lattice-
structure 20 allow scavenging of free radical species with high 
efficacy, and requires very little energy 18,21,19,22. The efficiency 
of ceria particles is determined by the increase in lattice 
parameters with decreasing particle size, which induces specific 
control of oxygen vacancies and determines their reactivity 23. 
This ability of CeNP to participate in redox coupled reactions 
makes them promising candidates for biological and medical 
applications, 24 as reported previously for protection from 
radiation-induced cellular damage, 25 nerve cell protection, 26 
hepato-protection against monocrotaline hepatotoxicity, and 
prevention of cardiovascular myopathy 27, 28.  
However, recent reports have indicated that CeNP lead to 
oxidative stress and DNA damage, and in high doses promote 
radical formation, via a possible Fenton-like reaction 29,30,31,32. 
Incubation with CeNP induced cytotoxicity and genotoxicity 
after 72 h in HeLA cells, 33,34  hepatic toxicity, 35 pulmonary and 
extrapulmonary toxicity, 36 and neurotoxic effects due to 
depletion of serotonine 37. Various factors, including synthetic 
routes, composition, purity, particle size, surface charge, and 
the use of non-stabilized CeNP for in vitro studies 24 have been 
suggested as possible causes of their toxicity. In addition, 
possible CeNP aggregation in solution is responsible for a 
decrease in scavenging efficiency 22. Thus it is only by avoiding 
the CeNP toxicity and aggregation problems, whilst preserving 
their superantioxidant activity that effective solution can be 
found for the use of CeNP in the medical domain. 
In this paper, we introduce a strategy based on CeNP 
encapsulation in polymer nanoreactors (Figure 1) for 
simultaneously preserving the superantioxidant activity of 
CeNP, whilst preventing their aggregation and interaction with 
H2O2, and decreasing their toxicity without further particle 
stabilization.  
 
 
 
 
 
 
Figure 1 Schematic representation of CeNP nanoreactors based on CeNP 
encapsulation inside polymer vesicles for detoxification of ROS, without 
generation of new species by a Fenton like reaction.  
 
We chose to assemble nanoreactors from poly(N-
vinylpyrrolidone)-block-poly(dimethylsiloxane)-block-poly(N-
vinylpyrrolidone) (PDMS-PNVP) block copolymers, which 
were expected to generate vesicles with a membrane permeable 
to O2 and  ROS, as previously reported for other PDMS based 
copolymer vesicles 14,6. Polymer vesicles obtained by self-
assembling amphiphilic block copolymers represent efficient 
compartments for the encapsulation of active compounds and 
the design of nanoreactors 38. They have the advantages of 
membranes with higher mechanical stability than lipid-based 
vesicles (liposomes), while preserving low immunogenicity 12. 
The CeNP encapsulated inside polymer vesicles benefit from 
the shielding effect of the polymer membrane, which limits 
interaction with H2O2, and prevents interactions which lead to 
aggregation of nanoparticles. Inside the cavity of vesicles CeNP 
can actively regenerate, and scavenge various free radical 
species, which pass through the polymer membrane. The ability 
of CeNP nanoreactors to scavenge different ROS was followed 
by spin trapping EPR, while the stability of the polymer 
membrane to hydrogen peroxide was followed by UV-vis 
spectroscopy. Uptake of CeNP nanoreactors was studied on 
HeLa cells by flow cytometry, and confocal laser scanning 
microscopy, and its cytotoxicity was assessed by the MTS 
assay. In vitro activity of CeNP nanoreactors was established 
on cells exposed to oxidative stress induced by paraquat. Thus 
the combination of superantioxidant CeNP with polymer 
vesicles to generate nanoreactors represent an efficient strategy 
for fighting oxidative stress because it benefits from the unique 
regenerative activity of CeNP, while preventing aggregation 
and ROS generation via Fenton like reaction with H2O2, the 
two main causes of CeNP toxicity. 
Materials and Methods 
Materials  
 
4,4’-azobis(4-cyanovaleryl) chloride was synthesized by the 
reaction of 4,4’-azobiscyanopentanoic acid previously dried by 
azeotropic distillation from toluene, with phosphorus 
pentachloride (PCl5) according to the method reported in the 
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literature 39 (Sigma-Aldrich). 1-Vinyl-2-pyrrolidinone (Sigma-
Aldrich) was purified before use by vacuum distillation and 
kept under N2. Chloroform (Sigma-Aldrich) was dried over 
P2O5 and purified by distillation. Toluene (Sigma-Aldrich) was 
distilled over Na wire. Octamethylcyclotetrasiloxane (D4; 
Sigma-Aldrich) and 1,3-bis(3-aminopropyl)-1,1,3,3-
tetramethyldisiloxane (Alfa-Aesar) were used as received. 
Cerium oxide (CeO2) with average size around 25 nm, 
hypoxanthine (HX), xanthine oxidase 1 U mL-1 (XOD), 
diethylene triamine pentaacetic acid (DTPA), hydrogen 
peroxide (H2O2), 5,5-dimethyl-1-pyrroline N-oxide (DMPO), 
and Sepharose 2B, were purchased from Sigma-Aldrich and 
used as received. Doxorubicin was purchased from Beijing 
Zhongshuo Pharmaceutical Technology Development Co., Ltd. 
and was used as received. 10 mM phosphate saline buffer 
(PBS) (pH 7.4, 136 mM NaCl, 2.6 mM KCl) was prepared by 
dissolving 8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4 and 0.24 g of 
KH2PO4 in 800 mL ddH2O, adjusting the pH to 7.4 with HCl, 
and completing the volume to 1 L. 
Synthesis of triblock copolymers 
The synthesis of amphiphilic PDMS-PNVP triblock 
copolymers was previously described 40. Two different PDMS-
PNVP triblock copolymers (Scheme 1) were obtained starting 
from two α,ω-bis(aminopropyl) poly(dimethylsiloxane) (H2N-
PDMS-NH2), with 17 and 37 siloxane units. The two H2N-
PDMS-NH2 siloxanes were synthesized by equilibrium 
polymerization of D4 and APTES in the presence of the 
catalyst tetramethylamonium siloxanolate. Further, by 
condensation of H2N-PDMS-NH2 with 4,4-azobiscyanovaleryl 
chloride polydimethylsiloxanes with azo end groups were 
obtained. They were used as macroinitiators for radical 
polymerizations of N-vinylpyrrolidone, yielding two different 
PDMS-PNVP triblock copolymers (Scheme 1 and Table 1). 
 
Scheme 1. PDMS-PNVP triblock copolymer 
1H-NMR (400.1 MHz, CDCl3) δ/ppm = 3.7-3.85 (CH2-CH-N), 
3.0-3.2 (CH2-CH2-N-CO), 2.7-3.0 (CH2-CH2-CONH) 2.3-2.4 
(CH2-CH2-CH2-CO), 1.5-2.0 (CH2-CH-N-CO, CH2-CH2-CH2-
CO, CH2-CH2-CONH, CH2-CH2-C, CH2-CH2-C, CH2-CH2-
C(CH3)-CN), 1.45-1.50 ppm (CH2-CH2-CH2), 0.54 (m, -
SiCH2), 0.1 (Si-(CH3)2).  
The degree of polymerisation of the siloxane sequence (DP 
siloxane) was established from 1H-NMR spectra of H2N-
PDMS-NH2 synthesized in the first step. The degree of 
polymerisation of the vinyl sequence was calculated from the 
1H-NMR spectra of the three block copolymers with the 
relationship DP vinyl = DP siloxane*vinyl/siloxane molar ratio 
(Table 1). 
Table 1. Characteristics of PDMS-PNVP triblock copolymers. 
Polymer DP 
siloxane 
block 
(n) 
DP 
vinyl 
block 
(m) 
Vinyl/si
loxane 
molar 
ratio 
Mn 
(GPC) 
Mw/Mn F = 
Mn 
vinyl 
/Mn 
siloxa
ne 
PDMS-
PNVP1 
17 17 1/1 4198 1.52 1.34 
PDMS-
PNVP2 
37 30 0.8/1 6161 1.54 1.14 
1H-NMR spectra were recorded on a Bruker DPX-400 
spectrometer operated at 400 MHz in CDCl3 and processed 
with MestReNova software. Chemical shifts are reported in 
ppm relative to tetramethylsilane.  
Gel permeation chromatography (GPC) was used in order to 
determine the average molecular weight Mn of the polymers 
and their polydispersity index (PDI). These parameters were 
determined using a Viscotek GPC max system equipped with 
four Polymer Agilent PL gel columns (10 µm guard; mixed C; 
10 µm, 100 Å; 5 µm, 103 Å), using chloroform as eluent at a 
flow rate of 1mL min-1 at 40 °C. Signals were recorded with a 
refractive-index detector (RI) and calibrated against polystyrene 
standards (Agilent). 
Preparation of CeNP nanoreactors 
CeNP nanoreactors were formed using the film rehydration 
method 41. First, 1 mL of a 5 mg mL-1 solution in ethanol of 
PDMS-PNVP copolymers was slowly evaporated in a rotary 
vacuum evaporator at reduced pressure until a film formed on 
the flask wall. This polymer film was then rehydrated i. in PBS 
for 12 hours under magnetic stirring (to obtain empty 
polymersomes) ii. with a solution of 0.1 mM CeNP (to obtain 
loaded nanoreactors) and iii. a mixture of 0.5 mg/mL 
doxorubicin and 0.1 mM CeNP (to obtain co-encapsulated 
doxorubicin and CeNP- containing polymersomes for the study 
of the cellular uptake). After rehydration the solutions were 
extruded through 200 nm track edge polycarbonate filters 
(Whatman). The nanoreactors containing only encapsulated 
CeNP were separated by size exclusion chromatography (SEC) 
through a Sepharose 2B column. The CeNP content inside 
nanoreactors was determined by UV-Vis spectroscopy 
(absorbance at 320 nm characteristic for Ce4+), using an 
extinction coefficient of 9 x 10-5 M−1 cm-1 determined 
experimentally in PBS. 
EPR samples preparation for generation, trapping and 
decay profile of hydroxyl radicals in presence of free and 
encapsulated CeNP 
In order to monitor the changes in hydroxyl radical (HO.) 
concentrations, DMPO was used as a spin trap. DMPO actively 
traps HO. to form DMPO/OH adducts which are paramagnetic, 
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so detectable by EPR spectroscopy. Hydroxyl radicals were 
generated by a Fenton reaction by mixing 20 μl 1 mM FeSO4 
and 20 μl 10 mM H2O2 with 140 μl PBS, and were trapped by 
addition of 20 μl 1 M DMPO as reported in the literature 42. 
The samples containing free CeNP by mixing 100 μl free CeNP 
(concentration ranging from 0.03 to 5 mM) with 20 μl 1mM 
FeSO4 and 20 μl 10 mM H2O2 (HO
. generation) in 40 μl PBS. 
In order to spin trap HO.  20 μl 1 M DMPO were added in the 
last step of sample preparation. The samples containing CeNP 
nanoreactors were prepared in a similar manner by mixing 100 
μl CeNP nanoreactors with 20 μl 1mM FeSO4, 20 μl 10 mM 
H2O2, and 20 μl 1 M DMPO in 40 μl PBS. All the mixtures 
were incubated for 10 min before measuring their EPR spectra. 
In the measured solutions the final concentration of CeNP 
varied from 2.5 to 0.015 mM.  
The ability of CeNP to generate hydroxyl radicals in a Fenton 
like reaction with hydrogen peroxide was tested by mixing 100 
μl CeNP solution (5 mM or 0.03 mM) with 20 μl H2O2 (10 
mM) and 20 μl 1 M DMPO in 60 μl PBS.  
EPR sample preparation for generation, trapping and 
decay profile of superoxide radicals in presence of free and 
encapsulated CeNP  
DMPO superoxide adducts (DMPO/OOH) were generated by a 
modification of previously published protocols 43. Briefly, 20 μl 
1 M DMPO was mixed with 100 μl 1 mM HX, 10 μl XO (to 
generate continuous superoxide radicals O2
.-), and 70 μl PBS.  
DMPO superoxide adducts were generated in the presence of 
free and encapsulated CeNP by mixing 50 μl CeNP (0.018 to 
3.75 mM) with 100 μl 1 mM HX, 10 μl XO (O2
.- generation), 
with DMPO (for spin trapping) and 20 μl PBS. All the samples 
were incubated for 10 min before measurement to achieve the 
maximum intensity of DMPO-OOH. 
Viability assay 
HeLa cells were seeded in 200 µL DMEM culture medium 
containing 10% FCS and 2 % Pen Strep antibiotics at a density 
of 2 x 104 cells per well in a 96 well plate and incubated for 24 
h at 37°C and 5% CO2. Cells were then incubated in 140 µL 
DMEM culture medium for another 24 h in the presence of 60 
µL CeNP loaded nanoreactors or free CeNP in PBS. The media 
was then removed, the cells washed with PBS, and fresh media 
and 20 µL MTS assay solutions (Promega) were added, and 
incubated for another 2 h. The absorbance at 490 nm was 
measured using a well plate reader (SpectraMax) and 
normalized against control cells to determine 100% viability. 
Background corrections were made based on media incubated 
with the MTS assay solution.  
Cellular uptake and in vivo stability experiment 
HeLa cells were cultured at a density of 5x104 cells per well in 
an 8-well Lab-Tek plate (Nalge Nunc International, USA) for 
24h in DMEM culture medium. Afterwards, 100 µg/ml PDMS-
PNVP1-CeNP or PDMS-PNVP2-CeNP nanoreactors 
(considering the polymer concentration) were incubated in the 
presence of the cells for additional 24 h. Then, the cells were 
stained with Hoechst 3342 (5mg/ml) and Cell mask Deep Red 
(5 mg/ml) for 10 min and 5 min, respectively. After rinsing 
with PBS, cells were imaged with a confocal laser scanning 
microscope (Carl Zeiss LSM510, Germany) equipped with a 
63x water emulsion lens (Olympus, Japan). The confocal laser 
scanning microscopy (CLSM) micrographs were recorded in 
multitrack mode and the setting (gain and contrast) of each 
fluorescent dye was adjusted individually: Hoechst 3342 was 
excited at 405 nm in channel 1, Deep Red at 633 nm in channel 
2 and Doxorubicin at 543 nm in channel 3. The images were 
recorded using Carl Zeiss LSM software (version 4.2 SP1). 
Control micrographs were recorded with the same settings as 
the sample images. 
Cellular uptake was quantified by flow cytometry analysis. 
1x105 HeLa cells were seeded in DMEM culture medium in a 
24-well plate and cultured for 24 h at 37°C in a humidified CO2 
incubator. After 24h the medium was exchanged and replaced 
with fresh medium containing 100 µg/ml doxorubicin-
containing CeNP-nanoreactors (PDMS-PNVP1-CeNP (0.0036 
mM CeNP), PDMS-PNVP1-CeNP (0.003 mM CeNP), 
respectively). Doxorubicin was co-encapsulated together with 
CeNPs as a fluorescent marker for the cellular uptake of the 
nanoreactors. For flow cytometry cells were washed with PBS, 
trypsinized, centrifuged, resuspended in 1 ml of PBS and put on 
ice. Flow cytometry was measured with a flow cytometry setup 
(BD Bioscience, USA) by analysing the fluorescent signal of 
doxorubicine of a total of 10,000 cells for each condition. Data 
were processed using Flowing Software 2.5.0 (Turku Centre for 
Biotechnology, Finland). 
Cell viability in the presence of ROS source 
HeLa cells were incubated with CeNP nanoreactors as 
described above for the flow cytometry experiment. After 24 h 
incubation with CeNP nanoreactors, the cell medium was 
exchanged and replaced by fresh medium containing 2mM 
paraquat to induce ROS in the cell. To determine viability, cells 
were stained with propidium iodide (PI, 50 µg/ml) 7 and flow 
cytometry measurements were performed. Control cell stained 
with PI was considered as 100% viable.  
 
Methods 
Dynamic and static light scattering (DLS, SLS) were used to 
determine the sizes of the free CeNP and CeNP containing 
nanoreactors. Measurements were performed on an ALV 
(Langen, Germany) goniometer, equipped with an ALV He-Ne 
laser (λ = 632.8 nm) using serial dilutions to produce polymer 
concentrations ranging from 0.12 to 2 mg/mL. Light scattering 
was measured in 10 mm cylindrical quartz cells at angles 
between 30 and 150o at 293 K. The photon intensity auto 
correlation function g2(t) was determined with an ALV-5000E 
correlator. Data were processed using ALV static & dynamic fit 
and plot software (version 4.31 10/01). SLS data were 
processed according to the Guinier-model and DLS data by 
using a Williams-Watts function. 
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Transmission electron microscopy (TEM) was used for 
characterization of the morphology of free CeNP and CeNP 
nanoreactors. Measurements were performed on a Philips 
EM400 electron microscope operating at 100 kV. Polymersome 
dispersions were deposited on a carbon-coated copper grid and 
negatively stained with 2% uranyl acetate solution. 
UV-Vis spectroscopy was used to determine the concentration 
of Ce4+ in various CeNP samples. Absorption spectra were 
measured in 1 cm quartz and silica glass cuvettes (Hellma) 
using a Specord 210 plus spectrometer (Analytik Jena, 
Germany) with a slit width of 4 nm. In order to determine 
CeNP concentrations in samples of loaded polymersomes, the 
absorption was measured at 320 nm, which is characteristic for 
Ce4+ 19. An extinction coefficient of 9 x 10-5 M−1 cm-1 
(determined experimentally by a dilution series in PBS) was 
used. 
Electron paramagnetic resonance (EPR) measurements were 
performed on a Bruker CW EPR Elexsys-500 spectrometer 
equipped with a variable temperature unit. Spectra were 
recorded at 298 K with the following parameters: microwave 
power 2 mW, conversion time 30 ms, number of scans up to 20, 
resolution 2048 points, modulation amplitude 1 G, sweep width 
100 G. The hyperfine couplings of the spin adducts were 
determined by simulating the spectra using the WinSim 
(NIEHS/NIH) simulation package 44; for spectra that consisted 
of a superposition of contributions from different adducts or 
radicals, the fitting also determined the relative intensity of 
each component with a typical margin of error of 5% in 
multicomponent spectra. 
FTIR spectra were recorded on a Bruker Alpha FTIR 
spectrometer (Bruker Optic GmbH, Ettlingen, Germany) to 
show the structure of CeNP. 
X-ray Diffraction (XRD) Measurements were performed on a 
Siemens D5000 diffractometer using Cu Kα radiation generated 
at 40 kV and 30 mA. Samples were scanned with scan rate of 
0.020°/step in the range of 2θ = 20-80° and 1 s/step. The 
Debye-Scherrer equation was applied to calculate crystallite 
diameters. 
dXRD = K λ/ β cos θ (1), where dXRD is the crystallite diameter, K is a 
constant estimated as 0.941, λ is the wavelength of radiation, β 
is the peak width at half height in radians, and θ is the angle of 
reflection. 
 
Result and discussion 
We engineered nanoreactors by encapsulation of CeNP inside 
polymer vesicles in order to solve their toxicity issues, by 
avoiding aggregation in solution and shielding them from H2O2, 
while preserving their ability to scavenge free radicals.  The 
effectiveness of this procedure is described below. 
Characterization of CeNP 
First, we characterized CeNP by a combination of XRD, FTIR, 
DLS and TEM. XRD powder spectrum of CeNP indicated 
(111), (200), (220), (311), (400), (331), (420) and (422) 
reflections (Figure S1A), which correspond to the 
polycrystalline cubic structure of CeO2 
45. As expected, CeNP 
gives isolated narrow peaks in XRD due to its cubic fluorite 
structure 23. The crystallite size was calculated based on 
Scherrer's equation (1), and was equal to 20 nm.  
FT-IR spectrum of CeNP (Figure S1B) shows the band at 468.2 
cm-1, characteristic for Ce-O stretching band and a broad band 
at 704.3 cm-1 due to Ce-O-C mode, indicating the presence of 
CeO2 
46, 47. The bands at 1405 and 2975.2 cm-1 correspond to 
OH groups from physically adsorbed water 47.  
DLS data indicate that CeNP have a hydrodynamic radius of 18 
nm and a narrow size distribution. As the size of the CeNP is 
affecting its catalytic properties 48 a uniform distribution of the 
particles is required.  
TEM images (Figure S2A) shows CeNP with a granular 
morphology, and a mean radius of (14 nm). The morphology of 
CeNP was was reported to affect their properties, nanorods and 
nanotubes exhibiting a higher catalytic activity than octahedral 
or grain- like CeNP 49. However, as granular CeNPs were 
reported to exhibit more than 35% of the catalytic activity of 
nanorods 23, we used them for generation of nanoreactors 
because granular morphology is not expected to influence the 
self-assembly process of polymer vesicle formation. 
Morphology and size of empty and CeNP loaded PDMS-
PNVP nanoreactors 
Empty and CeNP loaded PDMS-PNVP polymer 3D assemblies 
were generated by self-assembly of PDMS-PNVP copolymers 
by the film rehydration method 50. We characterized the 3D 
assemblies by a combination of light scattering and TEM. 
Light-scattering allows measuring the radii of gyration (Rg) and 
the hydrodynamic radius (Rh) of the self-assembled objects, 
while Rg/Rh (ρ-parameter) reveals the morphology of the 3D 
assemblies. Both PDMS-PNVP copolymers self-assembled in 
spherical supramolecular structures with Rg around 112 and 118 
nm, and ρ values of 0.92 and 0.95 (Table 2). Values of the ρ-
parameter are close to the expected values for hollow spheres 
(1.0), indicating that PDMS-PNVP copolymers self-assemble in 
vesicles. 51 For CeNP loaded supramolecular structures Rg 
values are 55 and 62 nm, respectively (Table 2). ρ values 
around 0.93-0.95, characteristic for hollow structures, indicates 
that the encapsulation of CeNP did not affect the self-assembly 
process, although it induced a decrease in the size of the 
vesicles. 
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Table 2. Light scattering data for empty and CeNP loaded PDMS-PNVP 
nanoreactors.  
System Rg / nm Rh / nm ρ=Rg/Rh 
PDMS-PNVP1  112 121 0.92 
PDMS-PNVP1-CeNP 55 59 0.93 
PDMS-PNVP2 118 129 0.95 
PDMS-PNVP2-CeNP 62 65 0.95 
 
The smaller size of the PDMS-PNVP copolymers after loading 
with CeNP could be due to “guest influence” on the size of self-
assembled structures. This has been previously observed for 
poly(ethylene oxide)-block-poly(butadiene) (PEO-PB) vesicles, 
where the encapsulation of horseradish peroxidase caused a 
transition from worm-like micelles (576 nm) to spherical 
polymersomes (147 nm) 52. The same effect has also been 
shown with polystyrene-b-poly(isocyanoalanine(2-thiophen-3-
yl-ethyl)amide) (PS-PIAT) vesicles, which, depending of the 
nature of the encapsulated guest, resulted in a decrease in size 
of polymersomes from 250 nm to 100 nm 53. 
TEM was performed to visualize and compare the morphology 
and size of empty and CeNP loaded self-assembled structures. 
Spherical assemblies with radii of 80-120 nm were obtained for 
both tested copolymers in PBS buffer (Figure 2 A and B). Upon 
encapsulation of CeNP, both copolymers formed spherical 
assemblies with radii around 60 nm (Figure 2 C and D). The 
combination of LS and TEM data indicates that both selected 
copolymers, hydrated in the presence of CeNP, self-assemble 
into vesicles and encapsulate CeNP. 
 
 
 
 
200 nm
A)
200 nm
B)
100 nm
C)
100 nm
D)
 
Figure 2. TEM micrographs of PDMS-PNVP polymersomes formed by self-
assembly of block copolymers in PBS. (A) PDMS-PNVP1, (B) PDMS-PNVP2, (C) 
CeNP PDMS-PNVP1 based nanoreactor, (D) CeNP PDMS-PNVP2 based 
nanoreactor. 
The final concentration of CeNP encapsulated in PDMS-PNVP 
nanoreactors was determined by UV-Vis spectroscopy as 0.074 
mM CeNP for PDMS-PNVP1 vesicles and 0.064 mM for 
PDMS-PNVP2. Thus, encapsulation efficiencies of 74 and 64% 
respectively were obtained for an initial concentration of 0.1 
mM CeNP. This is much higher than previously described for 
other antioxidant nanoreactors (23% for superoxide dismutase 
encapsulation 14 and 46% for copper superoxide dismutase 
mimics 9. The probable number of CeNP per vesicle was 
identified as 2-3, for a medium diameter of 20 nm for CeNP. 
Encapsulation of CeNP inside nanoreactors prevents their 
aggregation, which is one of the main causes of toxicity 29.  
Stability of PDMS-PNVP-CeNP nanoreactors over time and 
in the presence of hydrogen peroxide 
Free CeNP (0.068 mM) aggregate and form larger structures of 
around 500 nm diameter after 6 hours in PBS (Figure S2 B), 
compared with 20 nm after 1 hour in PBS (Figure S2 A). In 
contrast, CeNP loaded PDMS-PNVP nanoreactors (containing 
0.068 mM CeNP) are stable even after three months storage at 
room temperature, with TEM images indicating that their 
morphology and size were unchanged (Figure S3 A and B). 
Reaction of CeNP with H2O2 is one of the leading causes of its 
toxicity. Thus the stability of CeNP loaded PDMS-PNVP 
nanoreactors in the presence of H2O2 was assessed by UV-vis 
spectroscopy. In the presence of H2O2, Ce
3+, which absorbs 
between 230 and 260 nm, is oxidized to Ce4+, which absorbs in 
the 300-400 nm range, 19 and is then reduced back to Ce3+ 54. 
Free CeNPs were reduced in the presence of H2O2 for 24 h 
(Figure 3 A), as shown by the decrease in the absorption peak 
at 320 nm for Ce4+, whereas for CeNP in PDMS-PNVP 
nanoreactors the intensity of absorption peak at 320 nm was 
unchanged even after 24 h exposure to H2O2 (Figure 3 B and 
C). This indicates that the polymer membrane is impermeable 
Page 6 of 14Nanoscale
N
an
os
ca
le
A
cc
ep
te
d
M
an
us
cr
ip
t
Journal Name ARTICLE 
This journal is © The Royal Society of Chemistry 2012 J. Name., 2012, 00, 1-3 | 7 
to H2O2 and that CeNP is completely protected inside the 
PDMS-PNVP nanoreactors.  
Polymer membrane lack of permeability for H2O2 has already 
been shown in a previous study performed on horseradish 
peroxidase loaded PDMS-PNVP nanoreactors 40. However, 
ROS penetrate the block copolymer membrane of such 
polymersomes 40.  
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Wavelength / nm  Figure 3. UV-vis spectra showing changes in the Ce3+/Ce4+ ratios in the presence of hydrogen peroxide for: free CeNP (A), and encapsulated CeNP in nanoreactors 
based on PDMS-PNVP1 (B), and PDMS-PNVP2 (C), respectively. 
Hydroxyl radical scavenging activity of CeNP and 
nanoreactors 
The half-life of hydroxyl radicals (HO.) in solutions at room 
temperature is quite low (100 µs) 55, but their formation and 
decay can be investigated by spin trapping EPR, in which the 
addition reaction of a free radical to a spin trap forms a more 
stable spin adduct with paramagnetic parameters that depend on 
the nature of the trapped radical 56. The characteristic 
DMPO/.OH spin adduct has a  half-life of around 15 min 57, and 
its EPR spectrum consists of four lines with peak intensity 
ratios of 1:2:2:1 and hyperfine coupling constants aN and aH for 
14N and 1H equal to 14.9 G (inset Figure 3A). Hydroxyl radicals 
were generated by a typical Fenton reaction involving Fe2+ and 
H2O2, 
42 and their scavenging activity by CeNP was estimated 
by analyzing the plots (time scans) for DMPO/.OH adducts in 
the absence (control) and presence of different concentrations 
of CeNP (0.015 - 2.5 mM). Similar time scans were performed 
for PDMS-PNVP1 and PDMS-PNVP2 nanoreactors loaded 
respectively with 0.037 and 0.032 mM CeNP. Time scans of 
the intensity of the DMPO/.OH adduct in the absence or the 
presence of free CeNP or CeNP nanoreactors are presented in 
Figure 4.  
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Figure 4. (A) Decay of DMPO/.OH adducts at 298 K in the absence (0), and the presence of CeNP of various concentrations measured after 10 min of HO . generation. 
(B) Decay of DMPO/.OH adducts at 298 K in the presence of free CeNP (0.03 mM), and encapsulated CeNP in PDMS-PNVP1 and PDMS-PNVP2 nanoreactors after 10 
min from the moment of HO. generation. The red downward arrow in the inset points to the monitored signal. 
The intensity of DMPO/.OH adducts decreased drastically in 
the presence of CeNP (Figure 4A), and in addition a slight 
decrease in the adduct stability for various concentrations of 
CeNP is observed (Table 3). In the absence of CeNP (control), 
the time scans for the DMPO/.OH adduct show a significant 
decrease with time, and a half-life (τ1/2) of 960 s, which is 
similar to the reported value 48, 58.  
Surprisingly, in the presence of 2.5 mM and 1.5 mM free CeNP 
the relative intensity of the DMPO/.OH adducts decreased, 
whereas the time scans did not, a result which suggests the 
continued generation of hydroxyl radicals. This represents the 
first evidence of the ability of CeNP to catalyse a Fenton-like 
reaction, although cerium chloride has been reported to catalyse 
a similar reaction 59. A second spin trapping EPR experiment 
evaluated the ability of CeNP to generate hydroxyl radicals in 
the presence of hydrogen peroxide. In the presence of 5 mM 
CeNP a multicomponent EPR spectrum was recorded. This was 
deconvoluted into a typical signal for the DMPO/.OH adduct, a 
signal assigned to DMPO/.H adducts, and a three line signal 
corresponding to decomposition of DMPO (Figure 5A). A 
slightly different EPR spectrum, with significantly lower 
intensity, was observed in the presence of 0.03 mM CeNP 
(Figure 5B), indicating the ability of CeNP to generate radicals 
by a Fenton-like reaction over a broad concentration range. The 
difference between the EPR spectra is due to a higher CeNP 
concentration (over two order to magnitude), which induces 
changes both in the relative intensity of various adducts and 
their linewidth. XRD and FT-IR spectra of free CeNP (Figure 
S1 A and B) show only the characteristic patterns of CeO2. As 
no pattern characteristic for iron oxide with (220), (311), (400), 
(331), (422), (511) and (440) reflections has been detected 60 it 
indicates no iron impurities in the system 61 (Figure S1A). In 
addition FT-IR spectrum of CeNP shows no characteristic 
bands for iron 637 and 695 cm-1 62 (Figure S1 B). The absence 
of iron characteristic band at 404 nm (in UV-vis spectrum 
Figure 3 A) indicate that no iron impurities were responsible for 
the Fenton like reaction induced by CeNP (if these impurities 
were present below the resolution limit of 0.01%). 
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Figure 5. Experimental and simulated spectra of the multicomponent EPR signal 
obtained by spin trapping of the species formed in the reaction between 
hydrogen peroxide and 5 mM CeNP (A), and between  hydrogen peroxide and  
0.03 mM CeNP (B). 
For lower CeNP concentrations (0.8 - 0.015 mM), the shapes of 
the decay profiles of the DMPO/.OH adducts (Figure 3A) were 
similar to those of the control with τ1/2 in the range 960 to 949 
seconds (Table 3). A significant decrease in τ1/2 was observed 
only for 0.015 mM CeNP (747 seconds), which provides 
evidence of a significantly higher scavenging effect than the 
oxidation effect for CeNP (Fenton like reaction). The ability to 
scavenge hydroxyl radicals is inversely proportional the 
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concentration of CeNP, consistent with particle aggregation, 63 
which resulted in a reduction of the number of catalytic sites 
available for radical scavenging 48.  
 
Table 3.τ1/2 for empty and CeNP-containing PDMS-PNVP vesicles.  
 
[CeNP]  
/mM 
0 0.8 0.6 0.5 0.05 0.03 0.015 PDMS-PNVP1-CeNP 
0.037 
PDMS-PNVP2-CeNP    
 0.032 
τ1/2 /s 960 964 948 949 949 949 747 804 927 
 
 
 
In the case of CeNP nanoreactors, the intensity of the 
DMPO/.OH signal recorded at the beginning of the 
measurement time was significantly higher than in the presence 
of the same concentration of CeNP (Figure 3B), while lower 
than in the absence of CeNP. This indicates a scavenging of 
hydroxyl radicals by CeNP-containing nanoreactors. The τ1/2 
value (Table 3) decreased from 949 seconds for free CeNP to 
927seconds for CeNP-containing PDMS-PNVP2 nanoreactors, 
and to 804 seconds for the CeNP-containing PDMS-
PNVP1nanoreactors. This decrease is due to the blocking of the 
Fenton-like reaction by encapsulating the CeNP inside the 
polymeric vesicles 52, and the ability of encapsulated CeNP to 
scavenge hydroxyl radicals. Preventing aggregation of CeNP 
explains the faster decay of the DMPO/.OH signal with the 
encapsulated CeNP samples. The lower decrease of the τ1/2  
value in the case of CeNP-containing PDMS-PNVP2 
nanoreactors than for CeNP-containing PDMS-PNVP1 
nanoreactors is due to the different CeNP encapsulation 
efficiency inside polymer vesicles. 
Superoxide radical scavenging activity of CeNP, and CeNP-
containing nanoreactors 
DMPO is one of the most widely used spin traps for superoxide 
radical detection (O2
.-), but has a major disadvantage of a very 
short adduct half-life (of about one min 64). In order to 
overcome the low stability of DMPO/.OOH adducts in aqueous 
solutions, a hypoxanthine – xanthine oxidase system (HX-XA) 
that is unaffected by the spin trap concentration 43 was used for 
constant and continuous generation of superoxide radicals.  
Maximum intensity of the DMPO/.OOH EPR spectrum was 
obtained after 10 min, and in order to assess the changes due to 
CeNP activity, and not to the signal decay induced by the 
DMPO/.OOH short half-life, EPR measurements were 
performed after 10 min incubation. In the absence of CeNP, a 
typical signal from the DMPO/.OOH adduct with aN 14.12 G, 
aHβ 11.34 G, and aHγ 1.59 G was obtained 
43 (Figure 6A, No 
CeNP).  
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Figure 6. (A) CeNP scavenging activity for superoxide radicals of various 
concentrations of CeNP, from 1.25 mM to 0.006 mM, compared to the CeNP free 
control sample.  Experimental and simulated EPR spectra of DMPO adducts in 
the absence (No CeNP), and in the presence of 1.25 mM CeNP (from figure 6A). 
(B) EPR spectra observed when superoxide radicals were generated by the HX-XA 
system in the presence of CeNP-containing PDMS-PNVP1 and CeNP-containing 
PDMS-PNVP2 nanoreactors. 
In the presence of 1.25 mM CeNP, the characteristic EPR 
spectrum for DMPO/.OOH adducts was not detected, and 
instead a two component spectrum corresponding to OH (aN 
14.9 G, aH 15.1 G) C-centred radical adducts were observed 
(DMPO/CH2-R) 
56. The presence of CeNP seems to favour the 
formation of DMPO C-centred radical adduct, while in the 
absence of CeNP a typical aminoxy signal was detected 56. The 
DMPO/.OH adduct signal was detected at concentrations of 
CeNP up to 0.006 mM, indicating a preference of CeNP to 
scavenge superoxide radicals, in agreement with reported data 
19. As the superoxide radicals are generated in a continuous 
manner in the system, the disappearance of the DMPO/ .OOH 
adducts can be related only with the scavenging ability of 
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CeNP, as already reported 48. Similarly, CeNP containing 
nanoreactors induced the disappearance of DMPO/.OOH signal 
(Figure 6B), due to their ability to efficiently scavenge 
superoxide radicals. 
In conclusion, spin trapping EPR indicates that CeNP loaded in 
PDMS-PNVP nanoreactors have a high scavenging activity for 
both hydroxyl and superoxide radicals, whilst showing no 
ability to generate ROS because of their membrane 
impermeability to hydrogen peroxide. 
Cellular uptake and cytotoxicity of CeNP-containing 
nanoreactors 
The internalization, stability, and cytotoxicity of CeNP-
containing nanoreactors were tested on HeLa cells. To 
investigate their uptake and stability inside cells, nanoreactors 
co-encapsulating CeNP and doxorubicin were prepared in 
similar conditions to those containing only CeNP. Doxorubicin 
was selected due to its ability to intercalate with cellular DNA 
when released in cells, and the overlying of fluorescence 
signals from doxorubicin and DNA stained with Hoechst 65,66. 
CeNP- and doxorubicin-containing nanoreactors (as seen from 
the UV-vis spectra measured after purification; data not shown) 
were up-taken by cells (Figure 7 A-A3 and B-B3), irrespective 
of the PDMS-PNVP molecular weight. 
B1) B2)
B3) B)
A1) A2)
A3) A)
 
Figure 7. HeLa cells incubated for 24 h with co-encapsulated CeNP and 
doxorubicin in PDMS-PNVP1 vesicles (0.0036 mM CeNP) (A), and in PDMS-PNVP2 
vesicles (0.003mM CeNP) (B). Violet channel: Hoechst DNA staining (A1, B1), 
green channel: Cell Mask Deep Red staining (A2, B2), and red channel: 
doxorubicin loaded vesicles (A3, B3). 
 
The fluorescence signal of doxorubicin did not significantly 
overlap the nucleus fluorescence signal, suggesting that the 
majority of nanoreactors remained intact after being taken up 
by HeLa cells. In addition, flow cytometry with doxorubicin- 
and CeNP-containing nanoreactors confirmed their uptake after 
24 h (Figure 8 A). The shifts of the peaks corresponding to 
CeNP-containing nanoreactors compared to the normal cells 
after 24 h, and 72 h (Figure 8 B), respectively indicate that 
PDMS-PNVP2 nanoreactors have higher uptake ability than 
PDMS-PNVP1 nanoreactors. 
 
Figure 8. Flow cytometry analysis of HeLa cells incubated without nanoreactors 
(yellow), and in the presence of CeNP- and doxorubicin-containing PDMS-PNVP1 
nanoreactors (red), and PDMS-PNVP2 nanoreactors (blue) for an incubation time 
24 h (A), and an incubation time of 72h (B). 
 
In order to evaluate the cytotoxicity of CeNP-containing 
nanoreactors, HeLa cells were incubated with CeNP, and 
CeNP-containing nanoreactors for 24 h, and 72h respectively. 
Cytotoxicity was assessed with the MTS assay. After 24 h 
incubation, free CeNPs were shown to be slightly cytotoxic 
(around 30% cell death), whereas CeNP-containing 
nanoreactors had almost no toxicity (Figure 9A). With a longer 
term exposure (72 h), the cytotoxicity of free CeNP was 
significantly higher (especially for concentrations > 10 µg/mL), 
with cell death reaching 51% (Figure 9B), in agreement with 
reported data 31,33. In contrast, after 72 h incubation the CeNP-
containing PDMS-PNVP1 nanoreactors showed cytotoxicity of 
around 10% while the cell death with the PDMS-PNVP2 
nanoreactors was about 30% (Figure 9B). The decrease in cell 
viability in the presence of the nanoreactors might be the result 
of small number of vesicles breaking during 72 h incubation 
time. This effect is extremely small for PDMS-PNVP1 
nanoreactors (10% cell death) compared with PDMS-PNVP2 
nanoreactors (30% cells death) for the same concentration of 
CeNP (51% cells death).  
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Figure 9. HeLA cell viability after incubation with free CeNP, and encapsulated 
CeNP in nanoreactors for (A) 24h, and (B) 72 h. 
No toxicity of the PDMS-PNVP polymer vesicles on HeLa 
cells was observed after 24 h or 72 h exposure, even at 
significantly higher polymer concentrations than that used to 
obtain nanoreactors (5 mg/mL), as shown for 50 mg/mL 
polymer (Figure S4).  
In order to investigate the intracellular activity of CeNP-
containing nanoreactors, cells were exposed to oxidative stress 
induced by addition of paraquat. After exposure to ROS, cells 
were analysed by PI staining, and flow cytometry to determine 
the viability 7. The viability of HeLa cells decreased to 60% 
after 24 hours incubation in the presence of paraquat. In 
contrast, the viability of HeLa cells pre-treated with CeNP-
containing nanoreactors or free CeNP and then with paraquat 
remained at a high level of around 85% for PDMS-PNVP2 
nanoreactors, and 96% for PDMS-PNVP1 ones, compared with 
the situation of incubation with free CeNP 0.004 mM 96% 
(Figure 10). The cell toxicity in the presence of paraquat and 
CeNP loaded nanoreactors (Figure 10) is higher than the 
toxicity of CeNP containing nanoreactors alone shown in 
Figure 9 A. This represents a clear proof that inside cells CeNP-
containing nanoreactors act as an efficient ROS detoxification 
system.  
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Figure 10. Viability of HeLa cells after 24 h. 1) Control cells; 2) HeLa cells exposed 
to paraquat; 3) HeLa cells exposed to paraquat in the presence of 0.004 M CeNP-
containing PDMS-PNVP1 nanoreactors; 4) HeLa cells exposed to paraquat in 
presence of 0.004 M CeNP-containing PDMS-PNVP2 nanoreactors; 5) HeLa cells 
exposed to paraquat in presence of free 0.004 M CeNP. 
Conclusions 
CeNP-containing nanoreactors were engineered by 
encapsulation of CeNP inside vesicles generated by self-
assembly of PDMS-PNVP triblock copolymers under 
physiological pH conditions. Spin trapping EPR established 
that CeNP have a dual activity, involving both scavenging and 
generation of reactive oxygen species in the presence of 
hydrogen peroxide. In contrast, CeNP loaded nanoreactors 
benefit from polymer membrane protection, which blocks 
access of hydrogen peroxide to the inner cavity where CeNP 
are located, and therefore exhibit only an efficient scavenging 
activity for both hydroxyl and superoxide radicals. Upon 
encapsulation, the nanorectors prevent the aggregation of 
CeNP, and the Fenton-like reaction with hydrogen peroxide, 
which are known to be the main reasons for CeNP toxicity. 
CeNP nanoreactors were taken up by HeLa cells, and showed 
almost no cytotoxicity, even after long incubation times. In 
addition, inside nanoreactors CeNP preserved their 
superantioxidant activity, for both hydroxyl and superoxide 
radicals. Indeed, inside cells exposed to oxidative stress CeNP-
containing nanoreactors were effective in ROS scavenging 
because of the regenerative redox chemistry of loaded CeNP. 
Compared to free CeNP, which induces significant cytotoxicity, 
CeNP-containing nanoreactors possess high superantioxidant 
activity, long term stability, and almost no toxicity. Our 
strategy for engineering CeNP-containing nanoreactors 
represents a straightforward solution to reducing CeNP toxicity 
whilst preserving their functionality, and serving to offer the 
nanoreactors as an efficient solution to fighting oxidative stress 
in a large variety of domains, ranging from medicine to 
environmental protection. 
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